Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07516626) titled 'Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer' on April 1.

Study Type: Observational

Primary Sponsor: Atlas University

Condition: Breast Cancer Locally Advanced Breast Cancer (LABC)

Recruitment Status: Not recruiting

Date of First Enrollment: June 2026

Target Sample Size: 40

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07516626

Disclaimer: Curated by HT Syndication....